Serous Cystadenocarcinoma, also known as cystadenocarcinoma, serous, is related to endometrial serous adenocarcinoma and ovarian serous cystadenocarcinoma. An important gene associated with Serous Cystadenocarcinoma is TP53 (Tumor Protein P53), and among its related pathways/superpathways are Endometrial cancer and Pleural mesothelioma. The drugs Etoposide and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include ovary and lymph node, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Decreased viability in pancreas lineage